Why is Targeting Ras in Cancer Treatment Challenging?
Targeting Ras is challenging due to its structure and function. The Ras protein has a smooth surface without obvious binding pockets, making it difficult for drugs to bind effectively. Additionally, Ras cycles between an active and inactive state, complicating efforts to inhibit its activity. The high abundance of GTP in cells further complicates competitive inhibition approaches.
